GADOVIST 1.0mmol / ml injectible solution medication leaflet

V08CA09 gadobutrol • Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media

Gadobutrol is a contrast agent used in magnetic resonance imaging (MRI) to highlight internal structures of the body. This gadolinium-based contrast agent helps doctors obtain clearer images of organs, blood vessels, and tissues, making it easier to diagnose conditions such as tumors, inflammation, or vascular lesions.

Gadobutrol is administered intravenously, usually just before or during the MRI procedure. The dose is determined by the doctor based on the patient's weight and the type of examination. The procedure is quick and generally well tolerated by most patients.

Side effects may include a sensation of warmth, metallic taste, nausea, or reactions at the injection site. In rare cases, severe allergic reactions or impaired kidney function may occur, especially in people with pre-existing kidney problems. It is important to inform your doctor about any conditions or allergies before the examination.

Gadobutrol is an effective and safe contrast agent for most patients, but its use requires medical supervision. Follow the medical team's instructions and report any unusual symptoms after the examination to prevent complications.

General data about GADOVIST 1.0mmol / ml

Substance: gadobutrol

Date of last drug list: 01-06-2025

Commercial code: W64838005

Concentration: 1.0mmol / ml

Pharmaceutical form: injectible solution

Packing volume: 7.5 ml

Product type: original

Price: 199.62 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BAYER AG - GERMANIA

Holder: BAYER AG - GERMANIA

Number: 10724/2018/05

Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-24h la 20-25°C

Pharmaceutical forms available for gadobutrol

Concentrations available for gadobutrol

1.0mmol/ml, 1mmol/ml